The accessibility of specialized endocrine care remains a critical variable in patient outcomes across different continents. Analysis of the Parathyroid Disorders Market region dynamics shows that while North America and Europe lead in surgical innovation, the Asia-Pacific region is becoming the fastest-growing hub for generic medication production. This regional specialization is...